利妥昔单抗联合二线方案治疗七例复发难治性霍奇金淋巴瘤患者疗效观察

OBJECTIVE: To investigate the efficacy and safety of Rituximab combined with second line regimen for treatment of relapsed and refractory Hodgkin lymphoma. METHODS: Seven patients with relapsed and refractory Hodgkin lymphoma were treated with Rituximab combined with second line regimen. Among them,...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342643/
https://www.ncbi.nlm.nih.gov/pubmed/26304082
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342643/
https://www.ncbi.nlm.nih.gov/pubmed/26304082
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.011

Ejemplares similares